Association of Low-Dose Aspirin, Breast Cancer Risk
Aspirin use has been associated with a reduced risk of colorectal cancer. However, there are conflicting data on aspirin’s protective effect in breast cancer (BC). It has been postulated that aspirin’s anticancer effects are due to inhibition of cyclooxygenase enzymes, which affect apoptosis, cell proliferation, invasiveness, migration, and downregulation of aromatase, an enzyme associated with estrogen receptor–positive BC. Read more.

Tamoxifen Adherence in BC Patients Based on CYP2D6 Phenotype
Endocrine therapy, which consists of tamoxifen or aromatase inhibitors, is utilized in early breast cancer (BC) to significantly reduce the risk of recurrence and to improve overall survival in patients with estrogen receptor–positive BC. Learn more about a study that evaluated adherence to endocrine therapy, cytochrome 2D6 genotyping, possible association between menopausal status, CYP2D6 activity, and estimated risk of recurrence.

Homeopathy Effectiveness in BC, Other Oncological Diseases
Homeopathy is a form of complementary and alternative medicine that is based on the “Law of Similars.” According to homeopathic principles, a substance that causes a disorder can be used to treat the condition if prescribed in a very low dosage. Learn more about a study set to identify the use, effectiveness, and potential harm of homeopathy in breast cancer (BC) and other oncological patients.